Abstract. Alternethanoxins A (1) and B (2) are fungal phytotoxins that are produced by Alternaria sonchi and have been recently characterized as new polycyclic ethanones. Triacetyl (3) and dimethyl (4) derivatives of compound 1 were evaluated together with alternethanoxins for their in vitro growth inhibitory activities in five human and one mouse cancer cell lines in comparison to the reference compound temozolomide (TMZ). Compounds 1-4 and TMZ displayed similar growth inhibitory activities, and these anticancer activities were equivalent in cancer cell lines that display certain levels of resistance to pro-apoptotic stimuli and those that are sensitive to pro-apoptotic stimuli. Of the six cancer cell lines under study, the human esophageal cancer cell line OE21 was the most sensitive to the four polycyclic ethanones. Computerassisted phase-contrast microscopy (quantitative videomicroscopy) revealed that compounds 1, 2 and 4 displayed cytostatic rather than cytotoxic growth inhibitory effects, while compound 3 appeared to have cytotoxic effects. Thus, this study creates a stimulus for further structure-activity investigations with respect to the anticancer activities of compounds belonging to the alternethanoxin group. The observed toxicity does not seem to be affected by the stereochemistry of C-6 of the B ring, the presence of a hydroxy group at C-1 or the presence of a furan ring joining rings A and C in alternethanoxin B. The anticancer activity (cytostatic versus cytotoxic) of this type of compound could be affected by the chemical moieties present at the hydroxy groups at C-4 and C-6, as was observed for the cytostatic and cytotoxic activities of derivatives 4 and 3, respectively.
Introduction
Phytopathogenic fungi are involved in several plant diseases; thus, their study is of critical importance. Considering the economic importance of many agrarian crops, several studies have attempted to understand the role of bioactive microbial metabolites in the pathogenic process. The chemical nature of these toxins ranges from low-molecular-weight compounds, such as all classes of terpenes, chromanones, butenolides, pyrones, macrolides, aromatic derivatives and amino acids, to high-molecular-weight compounds, such as proteins, glycoproteins and polysaccharides. As a result, many new phytotoxins have been reported (1) (2) (3) (4) (5) (6) (7) (8) . Phytotoxins, isolated from fungi that are pathogenic for weedy plants, are an important tool to realize new strategies for the control of plant infestations. Plants that infest economically important crops are another important problem, as they cause marked losses in crop production (7, 9, 10) . The original structures of several of these metabolites and the results of studies on their structure/activity relationships and the modes of action of some fungicides and phytotoxins (4-10) prompted us to investigate whether fungal metabolites belonging to the polycyclic ethanones (alternethanoxins) could display anticancer activities in vitro.
We used one mouse and five human cancer cell lines and the MTT colorimetric assay (11) (12) (13) (14) to determine the in vitro IC 50 growth inhibitory concentrations of alternethanoxins A (1) and B (2), two fungal phytotoxins produced by Alternaria sonchi and recently characterized as new polycyclic ethanones (15) , and triacetyl (3) and dimethyl (4) derivatives of compound 1. We compared the in vitro anticancer activity of compounds 1, 2, 3 and 4 to the activities associated with the reference compound temozolomide (TMZ), which is used to treat cancers that display detectable levels of resistance to pro-apoptotic stimuli, including glioblastomas (16, 17) and, in some cases, melanomas (16, 18) .
Materials and methods
Fungal culture filtrates. The fungus Alternaria sonchi Davis was isolated from diseased leaves of Sonchus arvensis, and a monoconidial isolate (S-102) was deposited into the culture collection of the All-Russian Research Institute of Plant Protection, Pushkin, Saint Petersburg, Russia. The isolate was maintained in sterile tubes containing potato-dextrose agar.
Fungal metabolites and their derivatives. A. sonchi was grown on autoclaved pearl barley in ten 1000-ml Erlenmeyer flasks in the dark for 21 days, as reported previously (15) . The solid culture (100 g) was dried and extracted according to a previously published protocol (19) with minor modifications. The organic extract was purified using a combination of silica gel preparative TLC to yield alternethanoxins A and B (1 and 2, 51 and 2.2 mg, respectively) as a homogeneous yellow and amorphous solid, respectively, as reported previously (15) . Alternethanoxin A was converted to the corresponding triacetyl-and dimethyl ether derivatives (3 and 4, respectively) through a reaction with acetic anhydride and pyridine and an ethereal solution of diazomethane, respectively, according to recently reported protocols (15) .
Determining IC 50 in vitro growth inhibition concentrations.
The overall growth levels of the human cancer cell lines were determined using the colorimetric MTT (3-[4,5-dimethylthiazol-2yl])-diphenyltetrazolium bromide, Sigma, Belgium) assay (11) (12) (13) (14) . Briefly, cell lines were incubated for 24 h in 96-microwell plates (at concentrations of 10,000-40,000 cells/ml culture medium depending on the cell type) to ensure adequate plating prior to cell growth determinations. The assessment of cell population growth using the MTT colorimetric assay is based on the capability of living cells to reduce the yellow product MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to a blue product, formazan, by a reduction reaction in the mitochondria. The number of living cells after 72 h of culture in the presence (or absence; control) of the various compounds was directly proportional to the intensity of the blue color, which was measured quantitatively by spectrophotometry using a Bio-Rad Model 680XR (Bio-Rad, Nazareth, Belgium) at a 570-nm wavelength (with a reference wavelength of 630 nm). Each experimental condition was run in sextuplicate (11) (12) (13) (14) .
We used one mouse and five human cancer cell lines that were obtained from the European Collection of Cell Culture (ECACC, Salisbury, UK), the American Type Culture Collection (ATCC, Manassas, VA, USA) and the Deutsche Sammlung von Mikroorganismen und Zellkulturen, (DSMZ, Braunschweig, Germany). The human cancer cell lines included the esophageal cancer line OE21 (ECACC code 96062201), the non-small cell lung cancer (NSCLC) line A549 (DSMZ code ACC107), the melanoma line SKMEL-28 (ATCC code HTB-72), the oligodendroglioma line Hs683 (ATCC code HTB-138) and the glioblastoma line U373 (ECACC code 89081403), while the mouse cancer cell line is the melanoma line B16F10 (ATCC code CRL-6475). The six cancer cell lines under study were cultured in RPMI medium (Invitrogen, Merelbeke, Belgium) supplemented with 10% heat-inactivated fetal calf serum, 4 mM glutamine, 100 μg/ml gentamycin and penicillin-streptomycin (200 U/ml and 200 μg/ml, respectively) (Invitrogen). Temozolomide (TMZ; Schering Plough, Brussels, Belgium) was used as a reference compound.
Computer-assisted phase-contrast microscopy (quantitative videomicroscopy). The direct visualization of the effects of alternethanoxins A and B and their derivatives on OE21 cell proliferation and migration was carried out with computerassisted phase contrast microscopy (quantitative videomicroscopy), as detailed elsewhere (20, 21) . OE21 cells were monitored for 72 h in the absence (control) or presence of the four compounds at their IC 50 growth inhibitory concentrations (as calculated using the MTT assay). Movies were created from the obtained time-lapse image sequences, which enabled a detailed screen for cell viability to determine whether the compounds induced cytostatic or cytotoxic effects (22) . All experimental conditions were performed in triplicate.
Results and Discussion
Alternaria sonchi, which has recently been proposed as a possible biocontrol agent of Sonchus arvensis, commonly called sowthistle and considered an important weed in Europe and North America, as it infests many habitats, including cultivated fields, showed to produce phytotoxins when grown in solid cultures (15) . The two toxins, alternethanoxin A (1) and B (2), were characterized as two polycyclic ethanones containing a benzochromen moiety (15) . Compound 2 differs from compound 1 in the inverted configuration at C-6 and the presence of a furan ring joining rings A and C (Fig. 1) . The structure of compound 1 was confirmed by preparing its triacetyl (3) and dimethyl ether (4) derivatives (15) . Compounds 1 and 2 did not demonstrate any antimicrobial activity (15) . The ethanone compounds that were most similar to alternethanoxin A appeared to be the acetophenones, namely cynandiones A-D, cynanchone and analogs, which were isolated from the root of different Cynanchum plant species and show potential pharmacological applications, such as growth inhibitory activity against T-24 tumor cells (23) .
The present study deals with the characterization of the in vitro anticancer properties of compounds 1, 2, 3 and 4. We adopted an in vitro pharmacological strategy that was similar to the one recently used to characterize the in vitro anticancer activities of various fungal metabolites (24) . We first determined the IC 50 in vitro growth inhibitory concentrations of these compounds using an MTT colorimetric assay in six distinct cancer cell lines, including four cancer cell lines that displayed various levels of resistance to pro-apoptotic stimuli and two cancer cell lines with high sensitivity to pro-apoptotic stimuli. The four cell lines that displayed detectable levels of resistance to pro-apoptotic stimuli included the human glioblastoma line U373 (17, 25) , the NSCLC line A549 (26), the melanoma line SKMEL-28 (27) and the esophageal cancer line OE21 (22) . The two cell lines that were sensitive to pro-apoptotic stimuli were the human oligodendroglioma line Hs683 (28) and the mouse melanoma line B16F10 (18, 27) . The data reported in Table I indicate that the IC 50 values for compounds 1, 2, 3 and 4 ranged between approximately 50 and >100 μM and that the four cancer cell lines that displayed detectable levels of resistance to pro-apoptotic stimuli were no more resistant to the anticancer effects induced by compounds 1-4 than were the cell lines that were sensitive to pro-apoptotic stimuli. In fact, one of the cell lines that were resistant to pro-apoptotic stimuli (22) , OE21, also displayed the highest sensitivity to the growth inhibitory effects of compounds 1-4 (Table I) . We were not able to obtain sufficient quantities of compounds 1-4 to accurately determine their IC 50 growth inhibitory concentrations for concentrations >100 μM in each of the six cancer cell lines (Table I) . Therefore, in Fig. 2 , we report the percentages of cancer cells in each of the six lines that resisted 100 μM-concentrations of compounds 1-4 during three days of culture in the presence or absence (control condition = 100%) of each compound. Fig. 2 reveals that compounds 1-4 induced growth inhibition at 100 μM ranging from 18% (compound 4 in U373 cells; p<0.05 compared to control) to 80% (compound 2 in OE21 cells; p<0.001 compared to control). Altogether, these data strongly suggest that an alternethanoxin backbone could be used to produce original derivatives that are intended to combat cancers that resist pro-apoptotic stimuli because more than 80% of the chemotherapeutics in use today to combat cancers are pro-apoptotic agents (29) , but numerous cancer types are naturally resistant to apoptosis, including gliomas (16, 30) , melanomas (31), pancreatic cancers (32), non-small cell lung cancers (33) , esophageal cancers (34) and metastatic cancers (35, 36) . It is therefore mandatory to identify novel therapeutics that kill cancer cells while resisting apoptosis.
The growth inhibitory activities for the compounds under study appeared to be similar to those observed for temozolomide in the six studied cancer cell lines. Temozolomide is an alkylating agent that contributes therapeutic benefits to glioblastoma patients (16) and in the experimental B16F10 melanoma model, in which TMZ appeared to be more efficient than cisplatin and as efficient as taxol, irinotecan and adriamycin (18) . As indicated previously, glioblastomas Table I . Determination of the in vitro IC 50 growth inhibitory concentrations of four polycyclic ethanones (1-4; see Fig. 1 ) and the reference compound temozolomide (TMZ).
The six cancer cell lines under study include the mouse melanoma B16F10 and the human melanoma SKMEL28, oligodendroglioma Hs683, glioblastoma U373, non-small cell lung cancer (NSCLC) A549 and esophageal OE21 cancer cell lines. and melanomas display high levels of intrinsic resistance to pro-apoptotic stimuli (30, 31) . Dacarbazine, a close chemical analog of TMZ, represents the standard chemotherapy for melanoma patients (18, 27) . Dacarbazine does not show higher growth inhibitory activity in vitro compared to temozolomide (27) .
The data reported in Table I and Fig. 2 demonstrate the sensitivity of OE21 cells to the four studied alternethanoxins. Therefore, we used this cell line to grossly decipher the mechanisms of action by which these compounds inhibit OE21 cell proliferation. The white and refringent clusters of cells in Fig. 3 represent cells that are detaching from the culture support and dying. These dying cells (in clusters) must not be confounded with the single, round, refringent cells that are undergoing mitosis (Fig. 3 ). It appears that compound 4 is purely cytostatic, while compound 3 is cytotoxic; compounds 1 and 2 appear to be cytostatic, but signs of cytotoxicity are apparent after 72 h of culture. Thus, it seems that minor modifications of the chemical structure of alternethanoxin A (1), leading to compounds 3 and 4, can significantly modify its anticancer pharmacological properties (Figs. 2 and 3) . These results suggest that the stereochemistry of the hemiacetalic hydroxy group at C-6, the phenolic hydroxy groups at C-1 and the presence of a furan ring joining rings A and C are not important chemical moieties for the in vitro anticancer activities of alternethanoxins. By contrast, modifications at C-6 and the phenolic hydroxy group at C-4 make it possible to change the cytotoxic activity of compound 3 to the cytostatic activity of compound 4. The current data relating to in vitro anticancer activity agree with the preliminary SAR results obtained when assaying compounds 1-4 for their phytotoxicity on the host weedy plant Cirsium arvense (15) .
In conclusion, the data from the present study are part of a larger story revealing that several natural compounds, including cardiotonic steroids (17, 26, 27) and Kahalalide F (37, 38) , have been recently identified as having the ability to kill apoptosis-resistant cancer cells through sustained proautophagic and/or lysosomal membrane permeabilization processes. Thus, it seems that the in vitro growth inhibitory activities displayed by compounds 1-4 in the present study, which are similar to those displayed by temozolomide, a compound used to combat cancers associated with dismal prognoses, and similar for 'apoptosis-resistant' and 'apoptosissensitive' cancer cells, are quite encouraging to enter into hemisyntheses intended to obtain alternethanoxin derivatives with higher activities against cancer cells that display intrinsic resistance to pro-apoptotic stimuli. We are currently pursuing these hemisyntheses and are attempting to decipher the exact mechanisms by which alternethanoxins are able to kill cancer cells.
